PYC Therapeutics Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
25
- Stock Symbol
-
PYC
- Investments
-
3
- Share Price
-
$1.25
- (As of Friday Closing)
PYC Therapeutics General Information
Description
PYC Therapeutics Ltd is a clinical-stage biotechnology company creating a new generation of RNA therapies for patients with genetic diseases. The Group is engaged in drug development and progressing the Company's drug pipeline through preclinical and clinical development. The Company operates in a single business segment comprising the discovery and development of novel RNA therapeutics, with a single geographical location in Australia.
Contact Information
Website
www.pyctx.comCorporate Office
- 6 Verdun Street
- Nedlands, Western Australia 6009
- Australia
Corporate Office
- 6 Verdun Street
- Nedlands, Western Australia 6009
- Australia
PYC Therapeutics Stock Performance
As of 13-Nov-2026, PYC Therapeutics’s stock price is $1.25. Its current market cap is $1.23B with 985M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.25 | $1.31 | $0.72 - $2.09 | $1.23B | 985M | 3.97M |
PYC Therapeutics Financials Summary
As of 30-Sep-2026, PYC Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 1,529,702 | 1,058,086 | 462,160 | 356,352 |
| EBITDA | (38,483) | (34,310) | (25,071) | |
| Net Income | (29,361) | (32,548) | (24,723) | |
| Total Assets | 487,593 | 119,716 | 60,984 | |
| Total Debt | 430 | 669 | 744 |
PYC Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PYC Therapeutics Patents
PYC Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026908994-A0 | Compound for treating neurodevelopmental disorders | Pending | 30-Oct-2026 | ||
| AU-2026908659-A0 | Compound for treating neurodevelopmental disorders iii | Pending | 16-Oct-2026 | ||
| AU-2026908557-A0 | Method of treating cardiomyopathy | Pending | 13-Oct-2026 | ||
| AU-2026908363-A0 | Method of treating cardiomyopathy | Pending | 06-Oct-2026 | ||
| AU-2026908269-A0 | Method of treating cardiomyopathy | Pending | 02-Oct-2026 |
PYC Therapeutics Signals
PYC Therapeutics Investments & Acquisitions (3)
PYC Therapeutics’s most recent deal was a Secondary Transaction - Private with Vision Pharma for . The deal was made on 13-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vision Pharma | 13-Mar-2022 | Secondary Transaction - Private | Pharmaceuticals | ||
| Vision Pharma | 01-Oct-2019 | Joint Venture | Pharmaceuticals | ||
| Dynamic Microbials | 24-Nov-2008 | Merger/Acquisition | Biotechnology |
PYC Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
PYC Therapeutics FAQs
-
When was PYC Therapeutics founded?
PYC Therapeutics was founded in 2001.
-
Where is PYC Therapeutics headquartered?
PYC Therapeutics is headquartered in Nedlands, Australia.
-
What is the size of PYC Therapeutics?
PYC Therapeutics has 25 total employees.
-
What industry is PYC Therapeutics in?
PYC Therapeutics’s primary industry is Drug Discovery.
-
Is PYC Therapeutics a private or public company?
PYC Therapeutics is a Public company.
-
What is PYC Therapeutics’s stock symbol?
The ticker symbol for PYC Therapeutics is PYC.
-
What is the current stock price of PYC Therapeutics?
As of 13-Nov-2026 the stock price of PYC Therapeutics is $1.25.
-
What is the current market cap of PYC Therapeutics?
The current market capitalization of PYC Therapeutics is $1.23B.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process